SCHEMBL32038

SCHEMBL32038

CC(O)S(=O)(=O)c1ccc(Br)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 10/20 0.55
CA12 O43570 3/20 0.55
CA14 Q9ULX7 2/20 0.55
MMP1 P03956 7/20 0.47
MMP9 P14780 7/20 0.47
MMP13 P45452 7/20 0.47
CA2 P00918 3/20 0.47
CA1 P00915 1/20 0.47
MMP8 P22894 1/20 0.47
PLCG1 P19174 1/20 0.45
MMP3 P08254 6/20 0.45
MMP7 P09237 6/20 0.45
KMT2A Q03164 1/20 0.43
MMP14 P50281 1/20 0.42
F2 P00734 2/20 0.42
PRSS1 P07477 2/20 0.42
PRSS2 P07478 2/20 0.42
PRSS3 P35030 2/20 0.42
CA9 Q16790 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL152957 0.82 MMP2 (0.53) MMP2CA12CA14MMP1MMP9
SCHEMBL10767453 0.80 MMP2 (0.49) MMP2CA12CA14MMP1MMP9
SCHEMBL5335059 0.80 GAA (0.52) MMP2CA12CA14MMP1MMP9
SCHEMBL17674087 0.79 MMP2 (0.44) MMP2CA12CA14MMP1MMP9
SCHEMBL14850017 0.78 MMP2 (0.50) MMP2CA12CA14MMP1MMP9
SCHEMBL21921004 0.78 CA12 (0.55) MMP2CA12CA14MMP1MMP9
SCHEMBL7758469 0.78 TSHR (0.52) MMP2CA12CA14MMP1MMP9
SCHEMBL9646612 0.78 MMP13 (0.34) MMP2CA12CA14MMP1MMP13
SCHEMBL26460446 0.78 MMP2 (0.50) MMP2CA12CA14MMP1MMP9
SCHEMBL8013573 0.78 MMP2 (0.55) MMP2CA12CA14MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014015675-A1 NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS HUTCHISON MEDIPHARMA LIMITED (CN) 2014-01-30 WO disclosed
WO-2014015830-A1 NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITION AND METHODS THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2014-01-30 WO disclosed
WO-2012040242-A1 SUBSTITUTED PROLINE INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2012-03-29 WO disclosed
WO-2012026106-A1 OPTICALLY ACTIVE NOVEL ANTI-INFLAMMATORY COMPOUND AND METHOD FOR PRODUCING SAME 国立大学法人 東京大学 (JP) 2012-03-01 WO disclosed